医学
他汀类
中止
血脂异常
副作用(计算机科学)
不利影响
重症监护医学
糖尿病
阿托伐他汀
内科学
内分泌学
计算机科学
程序设计语言
作者
Vishnu Priya Pulipati,Michael H. Davidson
标识
DOI:10.2217/fca-2020-0153
摘要
Dyslipidemia promotes atherosclerosis and causes cardiovascular diseases. Statins are potent lipid-lowering medications with a cardiovascular mortality benefit. They are generally safe and well tolerated but sometimes can be associated with side effects of variable severity. The most common side effect is statin-associated muscle symptoms. Uncommon side effects include new-onset diabetes mellitus and elevation in liver enzymes. These effects can lead to noncompliance and premature discontinuation of the medication. Hence, it is crucial to identify patients with true statin-associated side effects (SASE) to ensure optimal statin use. The appropriate evaluation of the patient before starting statins and proactive utilization of available diagnostic tests to rule out alternate etiologies mimicking adverse effects are essential for accurate diagnosis of SASE. In patients with true SASE, timely intervention with modified statin or non-statins is beneficial. Herein, we discuss key clinical trial data on statins and non-statins, and describe our center's approach toward patients with SASE.
科研通智能强力驱动
Strongly Powered by AbleSci AI